Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 9/20 | 0.48 |
| ▸ | MMP9 | P14780 | 8/20 | 0.48 |
| ▸ | MMP13 | P45452 | 7/20 | 0.48 |
| ▸ | MMP3 | P08254 | 7/20 | 0.47 |
| ▸ | MMP7 | P09237 | 7/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TACR2 | P21452 | 2/20 | 0.44 |
| ▸ | HPGDS | O60760 | 1/20 | 0.44 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5634849 | 0.85 | MMP1 (0.52) | MMP1MMP9MMP13MMP3MMP7 | |
| SCHEMBL5635564 | 0.84 | MMP1 (0.51) | MMP1MMP9MMP13MMP3MMP7 | |
| SCHEMBL4035027 | 0.83 | L3MBTL1 (0.47) | MMP1MMP9MMP13MMP3MMP7 | |
| SCHEMBL5634226 | 0.78 | MCHR1 (0.55) | MMP1MMP9MMP13MMP3MMP7 | |
| SCHEMBL5635556 | 0.78 | MMP1 (0.53) | MMP1MMP9MMP13MMP3MMP7 | |
| SCHEMBL4038558 | 0.76 | MMP1 (0.51) | MMP1MMP9MMP13MMP3MMP7 | |
| SCHEMBL5635339 | 0.75 | MMP1 (0.50) | MMP1MMP9MMP13MMP3MMP7 | |
| SCHEMBL1380921 | 0.75 | MMP1 (0.54) | MMP1MMP9MMP13MMP3MMP7 | |
| SCHEMBL13886800 | 0.73 | MMP1 (0.47) | MMP1MMP9MMP13MMP3MMP7 | |
| SCHEMBL5636064 | 0.72 | MCHR1 (0.51) | MMP1MMP9MMP13MMP3MMP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1592389-B1 | PIPERAZINE-2-CARBOXAMIDE DERIVATIVES | SERONO LAB (CH) | 2009-04-22 | — | — | EP | claimed |